Group One Trading, L.P. Bicycle Therapeutics PLC Transaction History

Group One Trading, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$16.75 - $26.1 $438,397 - $683,115	-26,173 Reduced 99.65%	91 $2,000
Q4 2023 Feb 14, 2024	SELL	$13.29 - $22.2 $730,444 - $1.22 Million	-54,962 Reduced 67.67%	26,264 $474,000
Q3 2023 Nov 09, 2023	SELL	$19.9 - $26.25 $54,545 - $71,951	-2,741 Reduced 3.26%	81,226 $1.63 Million
Q2 2023 Aug 09, 2023	BUY	$18.95 - $28.67 $673,255 - $1.02 Million	35,528 Added 73.35%	83,967 $2.14 Million
Q1 2023 May 12, 2023	BUY	$20.02 - $31.37 $193,293 - $302,877	9,655 Added 24.89%	48,439 $1.03 Million
Q4 2022 Feb 09, 2023	BUY	$20.37 - $32.9 $790,030 - $1.28 Million	38,784 New	38,784 $1.15 Million

111

40.8M

39.6K

24.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $436M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.